Cell Signaling Technology

JMJD1B/JHDM2B Antibody

#2621 · $394

100
Citing papers
17.6k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation10Adipose Tissue and Metabolism10Extracellular vesicles in disease10Adipokines, Inflammation, and Metabolic Diseases8Wnt/β-catenin signaling in development and cancer6Angiogenesis and VEGF in Cancer5Epigenetics and DNA Methylation5Cancer-related molecular mechanisms research4

Papers citing this product

1
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
Nature Genetics·2005·1.8k cit.·DOI
2
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Journal of Clinical Investigation·2010·985 cit.·DOI
3
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
Molecular Cancer·2011·699 cit.·DOI
4
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Journal of Neuroscience·2016·477 cit.·DOI
5
Blood flow controls bone vascular function and osteogenesis
Nature Communications·2016·409 cit.·DOI
6
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
International Journal of Oncology·2015·363 cit.·DOI
7
The biology of TREM receptors
Nature reviews. Immunology·2023·357 cit.·DOI
8
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis
Journal of Clinical Investigation·2007·284 cit.·DOI
9
Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy
Nature Communications·2020·278 cit.·DOI
10
Hypoxia and defective apoptosis drive genomic instability and tumorigenesis
Genes & Development·2004·277 cit.·DOI
JMJD1B/JHDM2B Antibody — Evidence — PubIndex